Search
Menu
Home
HTB
2020
March
27
27 March 2020
Contents
Editorial
HTB 27 March 2020: CoV-2 and COVID-2019 special edition
Treatment strategies
Early drugs being studied for COVID-19
PK and drug interactions
Drug-drug interactions and COVID-19
HIV prevention and transmission
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
COVID-19: pathogenesis
Clinical outcomes of adult inpatients with COVID-19
Clinical characteristics of COVID-19 in China
COVID-19 is associated with significant drops in CD4 count
CoV-2 viral load in throat saliva samples correlates with clinical outcomes from COVID-19
COVID-19: guidelines
US interim guidelines on COVID-19 and HIV
BHIVA statements on HIV and COVID-19
Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition)
Children’s HIV Association (CHIVA) statement on COVID-19
WHO guidance on severe acute respiratory infection when COVID-19 is suspected
NICE updates rapid COVID-19 guideline on critical care
US CDC clinical guidance for management of patients with confirmed COVID-19
French guidelines for protection of cancer patients against COVID-19
Guidelines for managing COVID-19 from the Survive Sepsis Campaign
IDSA resource center on COVID-19
COVID-19: transmission & prevention
Median estimated incubation period of COVID-19 is five days – but can be two weeks
Selected epidemiology links and papers for COVID-19
Rapid and point of care testing for SARS-CoV-2
Peer-review articles on COVID-19 and pregnancy
Sex, HIV and STIs during COVID-19 pandemic
COVID-19: research studies
Ongoing and planned studies for COVID-19
NEAT ID develop COVID-19 and HIV coinfection data dashboard
Open access publications on COVID-19 include Lancet, Nature, NEJM, JAMA, JID, CID and others
Open access publishing on US PubMed Central
Selected articles by UCSF: download 60 papers
COVID-19: on the web
Online information for people living with HIV
Online talks about COVID-19
PDFs
27 March 2020 vol 21 no 4
HTB RSS
Early access
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study
12 February 2025
IAS public letter: Why HIV could be poised for a monumental comeback
6 February 2025
Lenacapavir for PrEP submitted to EMA for EU and global use
4 February 2025
New mpox vaccination sites open in the UK
3 February 2025
All early access reports
Current issues
February 2025
January 2025
December 2024
Back issues
Special report
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
1 February 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate